Investing
Stock
Business
Politics

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025

April 28, 2025

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

previous post

Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement

next post

S&P 500 Rises from Bearish to Neutral, But Will It Last?

You may also like

Sranan Gold Announces Investor Webinar on Exploration Activities...

July 15, 2025

WESTERN COPPER AND GOLD PROVIDES UPDATE ON ESE...

July 15, 2025

AI Market Update: Q2 2025 in Review

July 15, 2025

Crypto Market Recap: Bitcoin Hits Record as Congress...

July 15, 2025

Global Outcry Mounts Over Trump’s Tariff Blitz Ahead...

July 15, 2025

Silver Crown Royalties Closes Final Tranche of its...

July 14, 2025

Tech 5: NVIDIA Hits Market Cap Milestone, Harmonic...

July 14, 2025

Sun Summit Commences Drilling and Provides Exploration Update...

July 14, 2025

Stallion Uranium Announces the Completion of Coyote Project...

July 14, 2025

Apollo Silver Enters into Investor Relations Agreement

July 14, 2025

Leave a Comment Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

The Best Five Sectors, #27

July 15, 2025
Bitcoin Just Smashed $112K—Is a Surge to 124K Next?

July 15, 2025
From Hammer to Harami: Using StockCharts to Crack the Candlestick Code

July 15, 2025
AI Market Update: Q2 2025 in Review

July 15, 2025
WESTERN COPPER AND GOLD PROVIDES UPDATE ON ESE SUBMISSION

July 15, 2025

About us
Contacts
Privacy Policy
Terms and Conditions
Email Whitelisting

Disclaimer: globalinvestmentpulse.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 globalinvestmentpulse.com | All Rights Reserved

Investing
Stock
Business
Politics